Fatma Savran Oguz

Summary

Publications

  1. ncbi HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls
    Fatma Savran Oguz
    Istanbul University, Istanbul Medical Faculty, Department of Medical Biology Istanbul, Turkey
    Dis Markers 20:309-12. 2004
  2. doi Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status
    Gonca Emel Karahan
    Department of Medical Biology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Ren Fail 32:380-3. 2010
  3. doi Impact of HLA on the underlying primary diseases in Turkish patients with end-stage renal disease
    Gonca Emel Karahan
    Department of Medical Biology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Ren Fail 31:44-9. 2009
  4. ncbi HLA system affects the age-at-onset in chronic myeloid leukemia
    Fatma Savran Oguz
    Department of Medical Biology, Istanbul University, Istanbul Medical School, Istanbul, Turkey
    Am J Hematol 73:256-62. 2003
  5. doi Tissue chimerism analysis after donor lymphocyte infusion: a case of deceptive evidence
    Sevgi Kalayoglu-Besisik
    Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Hematology 13:92-4. 2008

Detail Information

Publications5

  1. ncbi HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls
    Fatma Savran Oguz
    Istanbul University, Istanbul Medical Faculty, Department of Medical Biology Istanbul, Turkey
    Dis Markers 20:309-12. 2004
    ..02). Our study supports other reports from different populations which showed that B*2705 and B*2702 were more frequent in Caucasian patients with SpA...
  2. doi Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status
    Gonca Emel Karahan
    Department of Medical Biology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Ren Fail 32:380-3. 2010
    ..02) having the highest frequency in patients with sensitizing event history but no anti-HLA development suggesting that DRB1*07 might be associated with low risk of anti-HLA antibody formation...
  3. doi Impact of HLA on the underlying primary diseases in Turkish patients with end-stage renal disease
    Gonca Emel Karahan
    Department of Medical Biology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Ren Fail 31:44-9. 2009
    ..Determination of HLAs as risk factors for primary diseases leading to ESRD might be beneficial in preventing progression to ESRD and recurrence of the primary disease post-transplantation...
  4. ncbi HLA system affects the age-at-onset in chronic myeloid leukemia
    Fatma Savran Oguz
    Department of Medical Biology, Istanbul University, Istanbul Medical School, Istanbul, Turkey
    Am J Hematol 73:256-62. 2003
    ..The mechanisms by which the HLA system modifies susceptibility to CML are unknown, likely to include immune and nonimmune ones, and worthy of further studies...
  5. doi Tissue chimerism analysis after donor lymphocyte infusion: a case of deceptive evidence
    Sevgi Kalayoglu-Besisik
    Department of Internal Medicine, Division of Hematology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Hematology 13:92-4. 2008
    ..Bone marrow and tissue chimerism revealed both recipient and donor cell population. We conclude that tissue chimerism analysis after DLI may not accurately document the cell origin...